Articles on Bayer
Displaying all articles
A case involving the potential dangers of glyphosate, the active ingredient in the weed killer Roundup, relates to broader efforts to protect consumers.
A case involving the potential dangers of glyphosate, the active ingredient in the weed killer sold as Roundup, could affect broader consumer-protection efforts.
The Federal Court has dismissed a class action against the makers of Roundup, saying there’s not enough evidence the active ingredient, glyphosate, causes cancer.
Mexico waffles on glyphosate ban but support for Agroecology stays strong.
The Covid-19 pandemic has laid bare Europe’s vulnerability to drug-supply disruption. Still, it remains by far the world leader in pharmaceutical products.
Bayer, the new owner of Monsanto, will need to up its PR efforts, in the wake of last week’s legal ruling on glyphosate weedkillers.
The global food system has been operating in post-truth mode for decades.
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…







